CINC up 43%. Here's what's happening:

(CINC) is trading 43% higher at $33.5 today. Shares of the promising biotech company are moving onto day two of elevated prices as traders continue to be bullish on news that it's treatment for hypertension had reached the middle stage of it's trial. The company has seen several price target upgrades as well which could be driving some of the bullish behavior.

CinCor Pharma has been trading between a 52-week high of $43.15 and a 52-week low of $13. The stock has a market cap of $1.26 Billion.

CinCor Pharma's mission is to advance promising clinical candidates toward marketing approval and improve the lives of patients suffering from cardio-renal diseases.